Company Invivo Therapeutics Holdings Corp Nasdaq
Equities
US46186M2098
Advanced Medical Equipment & Technology
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director of Finance/CFO | 54 | 19-01-13 | |
Heather M. Hamel
LAW | General Counsel | - | 17-07-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 16-06-07 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 19-11-07 |
C. Merrifield
CHM | Chairman | 73 | 14-11-10 |
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director/Board Member | 80 | 10-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,105,446 | 3,104,797 ( 99.98 %) | 0 | 99.98 % |
Company contact information
Invivo Therapeutics Holdings Corp.
Building 1400 West One Kendall Square
02139, Cambridge
+617 863 5500
http://www.invivotherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |